I n this issue of PNAS, the laboratory that discovered leptin (1) reports the development of a novel in vivo imaging strategy that permits noninvasive estimation of leptin expression (2) . They have engineered a BAC transgenic mouse strain expressing a luciferase reporter gene under the control of adipocyte-specific leptin regulatory sequences. Because of the ample evidence of correlation between lipid storage and leptin (3, 4) , they reasoned that a change in adipocyte mass would be accompanied by a parallel change in the expression of endogenous leptin and of the luciferase transgene. This was, in fact, the case. They were able to show in vivo differences in the adipocyte images of fed, fasting, and ob/ob transgenic animals. Luciferase activity fell gradually during a 3-day fast, but returned to baseline levels within 6 h of refeeding. Similarly, lipid depletion by infusion of recombinant leptin depleted adipocyte fat and, on discontinuation of leptin treatment, luciferase expression returned toward normal. Thus, in these two models, leptin expression as measured by the luciferase imaging is highly correlated with adipose tissue mass and can even be used as a surrogate for its measurement.
Applying the Technique
In their report, Birsoy et al. (2) employ this index of fat mass to show that fat loss by starvation or leptin treatment depletes triglycerides from adipocytes without impairing their viability or their ability to reaccumulate lipids. This confirms the demonstration by Hirsch's group (5) that adipocytes do not disappear during long-term semistarvation and, more recently, that leptin-induced lipid depletion does not destroy adipocytes but rather transforms them into mitochondria-rich, fat-burning cells (6) that can redifferentiate into normal adipocytes (7).
Birsoy and colleagues also observe that the withdrawal of leptin after depletion of adipocyte lipids is followed promptly by an increase in glycogen content of the adipocytes that seemed to precede lipogenesis. The authors postulate that glycogen could provide both glucose and glycerol precursors for triglyceride synthesis. The accumulation of glycogen in advance of triglyceride repletion is associated with induction of the enzymes required to produce the substrate for lipogenesis. It will be important to study adipocyte glycogen content, not only in normal adipocytes of lean animals recovering from lipid depletion, as was done here, but also in the hypertrophic and hyperplastic adipocytes in which overnutrition has stimulated lipogenesis. It should be pointed out that metabolic events in the fat repletion of normal adipocytes following a period of triglyceride depletion may differ from those of diet-induced lipogenesis.
Potential Applications
The most exciting feature of the study is the technique itself, which should make it possible to obtain real-time tracings of expression level of an adipocyte gene, and depending on the penetration depth for luciferase detection, perhaps of other genes in other tissues. Until now, gene expression chronology has required tissue samples from groups of animals killed at multiple arbitrary time points. The technique of Birsoy et al. (2) should permit continuous tracings of the expression level of genes of interest by means of reporter transgenes such as luciferase and, perhaps, other reporter proteins. Gene expression chronology may be very useful in attempting to define their functional role in various homeostatic responses to experimental perturbations or during the evolution of diseases in which random sampling of tissues reveals changes in gene expression and multiple pathologic events but fails to indicate their precise chronologic relationships. With this technique one could derive the temporal relationships between leptin expression and triglyceride accumulation and determine whether leptin expression levels in visceral adipocytes are lower than in subcutaneous adipocytes (8), a fact that may have pathogenic consequences.
Ectopic lipid deposition can cause lipotoxic damage to important organs, and this has been proposed as an etiology of the metabolic syndrome and type 2 diabetes (9, 10); the technique of Birsoy et al. (2) might permit the tracking of both leptin expression and expression of the leptin receptor, Lepr-b, in age-matched, diet-matched transgenic littermates. If so, one could test the hypothesis that prevention of the metabolic syndrome requires reciprocal down-regulation of adipocyte Lepr-b during overfeeding for storage of triglycerides in adipocytes (11), but full expression of Lepr-b in the peripheral targets to maintain leptin's lipooxidative actions in nonadipose tissue. If this hypothesis is correct, leptin would rank alongside insulin as a principal homeostatic regulator of nutrient metabolism.
The Emerging Role of Leptin
The discovery of leptin (1) 72 years after the isolation of insulin (12) radically changed the biomedical landscape at multiple levels. First, it revolutionized adipocyte biology. Traditionally considered to be an inert depository for surplus calories, adipocytes were abruptly catapulted into the forefront of endocrinology with the discovery of adiponectin in 1995 by Scherer et al. (13) and Maeda et al. (14) , followed by the identification of a myriad of previously unknown adipokines (15, 16) . Today, the fat cells enjoy an exalted status as an operational partner of the hypothalamus, to which they send and receive essential information concerning caloric surpluses or deficits. Without this crucial interplay via hormones and neurotransmitters, dysregulation of lipid and glucose metabolism ensues and familiar metabolic disorders result.
Second, like insulin, leptin is essential to health. Patients with leptin deficiency because of the absence of adipocytes (congenital generalized lipodystrophy) develop severe, early-onset metabolic syndrome with type 2 diabetes and are improved significantly when treated with recombinant leptin (17) . When adipocytes are present but congenitally unable to produce leptin, a syndrome of hyperphagia and massive obesity results and responds to replacement therapy with recombinant leptin (18) . Conversely, patients with adipocytes but defective leptin receptors exhibit a similar syndrome that is leptin-unresponsive (19) .
All of the foregoing disorders are extremely rare. But disorders involving leptin are now being recognized in common human clinical problems that have heretofore been ascribed to insulin abnormalities. For example, leptin resistance seems to coexist with insulin resistance in aging and in diet-induced obesity, and both hormones are increased in obesity. There are other hints of an overlapping dysregulation of nutrient homeostasis by the two hormones: diet-induced hyperinsulinemia upregulates lipogenesis, causing lipogenic insulin resistance (20) , and diet-induced hyperleptinemia of obesity up-regulates fatty acid oxidation (21) ; this is postulated to minimize ectopic lipid accumulation until the onset of leptin resistance, after which the metabolic syndrome begins and type 2 diabetes may develop (22) . These chronologic relationships can now be tested by using combinations of noninvasive imaging technologies. This approach may advance to a new level our understanding and management of diseases of lipid and glucose dysregulation.
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